Recent studies suggest that treatment with semaglutide (GLP-1RA) in combination with firsocostat (ACC-a inhibitor) and/or cilofexor (nonsteroidal FXR agonist) can further improve hepatic steatosis and thus NAFLD compared with semaglutide alone in exploratory efficacy analyses [113]
These trials also demonstrated a significant reduction in C-Reactive Protein (CRP) levels, reinforcing the hypothesis that suppressing the pro-inflammatory state may yield substantial clinical benefits in this patient population
Use these tools carefully and under guidance if you have GI conditions
WARNING Before using metformin, tell your health care provider about your medical history, especially if you have: kidney disease heart disease or congestive heart failure liver disease metabolic acidosis or diabetic ketoacidosis high ketone levels in your blood or urine you use insulin or other diabetes medications Talk to your health care provider if you are planning to become pregnant or if pregnant or breastfeeding
Se aplican costos adicionales, que incluyen consulta, atencin continua y manejo de efectos secundarios
It is that it gives us another way to build care around what the patient is feeling and what they want to improve